AXON Form 4: Director sold 580 shares at ~$871 each
Caitlin E. Kalinowski, identified as a director of Axon Enterprise (AXON), reported two separate sales of common stock on 08/07/2025 totaling 580 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Caitlin E. Kalinowski, identified as a director of Axon Enterprise (AXON), reported two separate sales of common stock on 08/07/2025 totaling 580 shares.
The filing shows a sale of 476 shares at a weighted-average price of $870.7414 and a sale of 104 shares at a weighted-average price of $872.0066. The two report lines list beneficial ownership amounts of 4,799 and 4,695 shares following the respective transactions. The Form 4 was executed through an attorney-in-fact and discloses the transaction details and weighted-average prices without additional commentary.
Insights
TL;DR Insider director executed small-volume sales totaling 580 shares at roughly $871 per share; filings disclose remaining beneficial ownership.
The two reported transactions are explicit sales rather than option exercises or other derivative actions, with weighted-average sale prices of $870.7414 and $872.0066. The entries show post-transaction beneficial ownership figures (4,799 and 4,695 shares) but do not reconcile into a single total ownership figure or provide context for the sales. From a market-materiality perspective, the disclosed volumes are modest relative to large-cap equity float and present routine insider selling activity rather than a material corporate event.
TL;DR Filing demonstrates compliance with Section 16 disclosure requirements; sales were executed via multiple trades and documented by weighted averages.
The reporting shows appropriate disclosure of transaction codes and weighted-average prices and includes an explanation that the sales were executed in multiple trades with price ranges provided. An attorney-in-fact signed the form, indicating representation in submitting the disclosure. The filing contains factual transaction-level detail but does not indicate any change in board status, employment, or other governance actions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 476 | $870.7414 | $414K |
| Sale | Common Stock | 104 | $872.0066 | $91K |
Footnotes (2)
- F1. The transaction was executed in multiple trades at prices ranging from $870.33 to $871.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. The transaction was executed in multiple trades at prices ranging from $871.335 to $872.33. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did AXON report in this Form 4?
Was the Form 4 signed directly by the reporting person?
Does the filing indicate these transactions were part of a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.